Hypertriglyceridaemia: an update.
Wierzbicki AS, Kim EJ, Esan O, Ramachandran R.
J Clin Pathol. 2022 Dec;75(12):798-806. doi: 10.1136/jclinpath-2021-207719. Epub 2022 Jun 16.
A Comprehensive Update on the Chylomicronemia Syndrome.
Goldberg RB, Chait A.
Front Endocrinol (Lausanne). 2020 Oct 23;11:593931. doi: 10.3389/fendo.2020.593931. eCollection 2020.
Severe hypertriglyceridemia: Existing and emerging therapies.
Malick WA, Do R, Rosenson RS.
Pharmacol Ther. 2023 Nov;251:108544. doi: 10.1016/j.pharmthera.2023.108544. Epub 2023 Oct 15.
The familial hyperchylomicronaemia syndrome.
Bijvoet SM, Bruin T, Kastelein JJ.
Neth J Med. 1993 Feb;42(1-2):36-44.
Familial Chylomicronemia Syndrome: A Clinical Guide For Endocrinologists.
Falko JM.
Endocr Pract. 2018 Aug;24(8):756-763. doi: 10.4158/EP-2018-0157.
Olezarsen, Acute Pancreatitis, and Familial Chylomicronemia Syndrome.
Stroes ESG, Alexander VJ, Karwatowska-Prokopczuk E, Hegele RA, Arca M, Ballantyne CM, Soran H, Prohaska TA, Xia S, Ginsberg HN, Witztum JL, Tsimikas S; Balance Investigators.
N Engl J Med. 2024 May 16;390(19):1781-1792. doi: 10.1056/NEJMoa2400201. Epub 2024 Apr 7.
Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome.
Witztum JL, Gaudet D, Freedman SD, Alexander VJ, Digenio A, Williams KR, Yang Q, Hughes SG, Geary RS, Arca M, Stroes ESG, Bergeron J, Soran H, Civeira F, Hemphill L, Tsimikas S, Blom DJ, O'Dea L, Bruckert E.
N Engl J Med. 2019 Aug 8;381(6):531-542. doi: 10.1056/NEJMoa1715944.
Familial hyperchylomicronaemia.
Wierzbicki AS, Reynolds TM.
Lancet. 1996 Nov 30;348(9040):1524-5. doi: 10.1016/s0140-6736(05)65951-x.
Genetics of Hypertriglyceridemia.
Dron JS, Hegele RA.
Front Endocrinol (Lausanne). 2020 Jul 24;11:455. doi: 10.3389/fendo.2020.00455. eCollection 2020.
Hyperchylomicronaemia due to lipoprotein lipase deficiency as a cause of false-positive newborn screening for biotinidase deficiency.
Santer R, Gokçay G, Demirkol M, Gal A, Lukacs Z.
J Inherit Metab Dis. 2005;28(2):137-40. doi: 10.1007/s10545-005-7060-5.
